Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle (Q39005887)
Jump to navigation
Jump to search
scientific article published on 6 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle |
scientific article published on 6 April 2014 |
Statements
1 reference
Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle (English)
1 reference
Matthieu Blanchet
1 reference
Camille Sureau
1 reference
Patrick Labonté
1 reference
6 April 2014
1 reference
1 reference
Identifiers
1 reference